A citation-based method for searching scientific literature

Michael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, Lisa Jerome, Mark Wagner, Joy Wymer, Julie Holland, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Lancet Psychiatry 2018
Times Cited: 153







List of co-cited articles
917 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
583
43

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Psychopharmacology (Berl) 2019
121
41

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
Marcela Ot'alora G, Jim Grigsby, Bruce Poulter, Joseph W Van Derveer, Sara Gael Giron, Lisa Jerome, Allison A Feduccia, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson,[...]. J Psychopharmacol 2018
66
57

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb,[...]. J Psychopharmacol 2016
484
36


Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton, Rick Doblin. J Psychopharmacol 2013
210
28

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot'alora G, Wael Garas, Casey Paleos, Ingmar Gorman,[...]. Nat Med 2021
141
28

Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Charles S Grob, Alicia L Danforth, Gurpreet S Chopra, Marycie Hagerty, Charles R McKay, Adam L Halberstadt, George R Greer. Arch Gen Psychiatry 2011
455
26

Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
Peter Gasser, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, Rudolf Brenneisen. J Nerv Ment Dis 2014
277
25

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
511
25

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Alicia L Danforth, Charles S Grob, Christopher Struble, Allison A Feduccia, Nick Walker, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson. Psychopharmacology (Berl) 2018
69
34

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Lisa Jerome, Allison A Feduccia, Julie B Wang, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C Mithoefer, Rick Doblin. Psychopharmacology (Berl) 2020
42
50

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A Feduccia, Michael C Mithoefer. Prog Neuropsychopharmacol Biol Psychiatry 2018
70
27

Safety pharmacology of acute MDMA administration in healthy subjects.
Patrick Vizeli, Matthias E Liechti. J Psychopharmacol 2017
72
25

MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
José Carlos Bouso, Rick Doblin, Magí Farré, Miguel Angel Alcázar, Gregorio Gómez-Jarabo. J Psychoactive Drugs 2008
79
22

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
399
18

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling,[...]. Psychopharmacology (Berl) 2018
266
18

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Katia C Andrade, Morgana M Novaes, Jessica A Pessoa, Sergio A Mota-Rolim, Flávia L Osório, Rafael Sanches, Rafael G Dos Santos,[...]. Psychol Med 2019
233
17

Psychedelics.
David E Nichols. Pharmacol Rev 2016
500
17

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths. J Psychopharmacol 2014
340
16

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
216
16

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Allison A Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Michael C Mithoefer, Rick Doblin. Front Psychiatry 2019
35
42


Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
Francisco A Moreno, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado. J Clin Psychiatry 2006
264
14

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
G J H Dumont, F C G J Sweep, R van der Steen, R Hermsen, A R T Donders, D J Touw, J M A van Gerven, J K Buitelaar, R J Verkes. Soc Neurosci 2009
143
13


Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
211
13

Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
283
12



The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Robin L Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B Wall, Bart Ferguson, Luke T J Williams, Leor Roseman, Stefan Brugger, Ineke De Meer,[...]. Biol Psychiatry 2015
71
16

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
Katherine A MacLean, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2011
290
12

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Friederike Holze, Patrick Vizeli, Felix Müller, Laura Ley, Raoul Duerig, Nimmy Varghese, Anne Eckert, Stefan Borgwardt, Matthias E Liechti. Neuropsychopharmacology 2020
73
16

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.
Katrin H Preller, Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Kraehenmann, Philipp Stämpfli, Matthias E Liechti, Erich Seifritz, Franz X Vollenweider. Curr Biol 2017
168
11

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality.
Patrick C Dolder, Yasmin Schmid, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Neuropsychopharmacology 2016
121
11

Human hallucinogen research: guidelines for safety.
Mw Johnson, Wa Richards, Rr Griffiths. J Psychopharmacol 2008
361
11

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton. Lancet Psychiatry 2016
122
11


The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K Bershad, Melissa A Miller, Matthew J Baggott, Harriet de Wit. J Psychopharmacol 2016
49
20

MDMA enhances emotional empathy and prosocial behavior.
Cédric M Hysek, Yasmin Schmid, Linda D Simmler, Gregor Domes, Markus Heinrichs, Christoph Eisenegger, Katrin H Preller, Boris B Quednow, Matthias E Liechti. Soc Cogn Affect Neurosci 2014
153
10

Long-lasting subjective effects of LSD in normal subjects.
Yasmin Schmid, Matthias E Liechti. Psychopharmacology (Berl) 2018
82
12

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).
Matthew B Young, Seth D Norrholm, Lara M Khoury, Tanja Jovanovic, Sheila A M Rauch, Collin M Reiff, Boadie W Dunlop, Barbara O Rothbaum, Leonard L Howell. Psychopharmacology (Berl) 2017
41
24

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
Ben Sessa, Laurie Higbed, David Nutt. Front Psychiatry 2019
40
25

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
Philip E Wolfson, Julane Andries, Allison A Feduccia, Lisa Jerome, Julie B Wang, Emily Williams, Shannon C Carlin, Evan Sola, Scott Hamilton, Berra Yazar-Klosinski,[...]. Sci Rep 2020
19
52


Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.
Cédric M Hysek, Linda D Simmler, Valentina G Nicola, Nerina Vischer, Massimiliano Donzelli, Stephan Krähenbühl, Eric Grouzmann, Jörg Huwyler, Marius C Hoener, Matthias E Liechti. PLoS One 2012
116
9

Differential effects of MDMA and methylphenidate on social cognition.
Yasmin Schmid, Cédric M Hysek, Linda D Simmler, Molly J Crockett, Boris B Quednow, Matthias E Liechti. J Psychopharmacol 2014
87
10

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H Preller, Franz X Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Biol Psychiatry 2015
205
9

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Anna Rickli, Olivier D Moning, Marius C Hoener, Matthias E Liechti. Eur Neuropsychopharmacol 2016
140
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.